Abiomed (ABMD) Tops Q1 EPS by 12c

Abiomed (NASDAQ: ABMD) reported Q1 EPS of $0.20, $0.12 better than the analyst estimate of $0.08. Revenue for the quarter came in at $73.4 million versus the consensus estimate of $66.27 million.

Abiomed sees FY2015 revenue of $300-310 million, versus prior guidance of $285-295 million and the consensus of $292.4 million.

For earnings history and earnings-related data on Abiomed (ABMD) click here.

You May Also Be Interested In

• uCloudlink Group Inc. (UCL) Misses Q2 EPS by 1c ; Offers Guidance
• Fabrinet (FN) Tops Q4 EPS by 29c, Beats on Revenue; Offers Guidance
• Duos Technologies Group, Inc. (DUOT) Tops Q2 EPS by 163c